Women who inherit the BRCA1/2 gene have up to an 85% lifetime chance of developing breast cancer and a 63% chance of developing ovarian Cancer. Since the publication and update of the UK Nice National Guidelines (2015) for women with a strong family history and Angelina Jolie, the famous American actress declared her status and her surgery, many more women are seeking testing in order to undergo bilateral risk-reducing mastectomy and oophorectomy. Very little is known about the longer-term effect on the woman her partner and her relatives following diagnosis and bilateral mastectomy from a qualitative research perspective. Aim - The aim of this study, therefore, was to explore, interpret and develop an understanding of the experiences of wo...
Background: When women from families with a known BRCA1 or BRCA2 mutation test negative for the fami...
Pathogenic mutations in two autosomal dominant genes, BRCA1 and BRCA2 , with high penetrance are ...
Background Females with BRCA 1/2 gene mutations have increased lifetime risk of breast and ovarian c...
Women who inherit the BRCA1/2 gene have up to an 85% lifetime chance of developing breast cancer and...
Women who inherit the BRCA1/2 gene have up to an 85% lifetime chance of developing breast cancer and...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
Item does not contain fulltextGenetic testing enables women at risk for hereditary breast and/or ova...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
Among women in the United States, breast cancer is the second most commonly diagnosed cancer and is ...
Background: Women who carry BRCA1/2 mutations have a significantly elevated risk for breast and ovar...
Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whethe...
In the mid-1990s, genetic testing was introduced for two breast and ovarian cancer predisposition ge...
Aim of this paper is to allows to analyze a topic of great relevance and media interest such as the ...
Women with a family history of breast or ovarian cancers may be eligible for genetic testing to see ...
Women who harbor mutations in breast cancer susceptibility genes are at an increased lifetime risk o...
Background: When women from families with a known BRCA1 or BRCA2 mutation test negative for the fami...
Pathogenic mutations in two autosomal dominant genes, BRCA1 and BRCA2 , with high penetrance are ...
Background Females with BRCA 1/2 gene mutations have increased lifetime risk of breast and ovarian c...
Women who inherit the BRCA1/2 gene have up to an 85% lifetime chance of developing breast cancer and...
Women who inherit the BRCA1/2 gene have up to an 85% lifetime chance of developing breast cancer and...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
Item does not contain fulltextGenetic testing enables women at risk for hereditary breast and/or ova...
The recent identification of Breast Cancer 1 (BRCA1) and BRCA2 genes offers an opportunity for high-...
Among women in the United States, breast cancer is the second most commonly diagnosed cancer and is ...
Background: Women who carry BRCA1/2 mutations have a significantly elevated risk for breast and ovar...
Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whethe...
In the mid-1990s, genetic testing was introduced for two breast and ovarian cancer predisposition ge...
Aim of this paper is to allows to analyze a topic of great relevance and media interest such as the ...
Women with a family history of breast or ovarian cancers may be eligible for genetic testing to see ...
Women who harbor mutations in breast cancer susceptibility genes are at an increased lifetime risk o...
Background: When women from families with a known BRCA1 or BRCA2 mutation test negative for the fami...
Pathogenic mutations in two autosomal dominant genes, BRCA1 and BRCA2 , with high penetrance are ...
Background Females with BRCA 1/2 gene mutations have increased lifetime risk of breast and ovarian c...